tirzepatide surpass 5 Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism Systolic blood pressure reduction with

Tirzepatide is a novel medication that acts as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) receptors

Experimentally resolved GLP-1R complexes with peptide agonists (e.g., GLP-1, exendin-4, and clinically used GLP-1 analogs) commonly exhibit contacts distributed across extracellular regions and the TM bundle similar to those found with neuromedin C, being characterized by cooperative interactions that stabilize active conformations required for G protein coupling (Kawai et al., 2020)

Tirzepatide itself doesnt work like a sleeping pill

Can it be stacked with other supplements